Restarting clinical research at NUH
Since the COVID-19 pandemic was first declared we have taken a number of steps to protect our patients involved in clinical research. These included the suspension of non COVID-19 research trials and the safe continuation of trials providing essential clinical treatments.
Our staff and resources were redeployed into the national priority research programme to rapidly evaluate new treatments, tests and a vaccine for COVID-19. Thousands of patients and staff have now taken part in vital COVID-19 research at NUH, for which we are incredibly grateful.
Continuing COVID-19 research
Coronavirus will be with us for some time to come and our clinical research will continue to be a vital part of finding effective treatments and the longer-term protection of our families and communities. We will remain flexible, so that we can respond to changes in COVID-19 infection rates and the more localised information from the NHS test and trace service.
As the number of COVID-19 cases continues to reduce, we are able to release some staff, resources and facilities back to the delivery of our planned programme of clinical research, whilst maintaining our COVID-19 research. This will enable us to increasingly restart trials and to develop new studies which meet the important health needs of our patients and communities.
We are putting the safety of our patients and our staff as the number one priority in restarting our research. Information about Restarting Research for patients can be found on our Patient and Public Involvement pages.
Restart process for researchers
In order to prioritise the trials and studies which we are able to restart, our Research & Innovation department has put in place a Restart Research process so that Principal Investigators, research teams and frontline research delivery staff have clarity about restarting, or opening new, trials.
We have produced a number of documents to explain this process and the actions that Principal Investigators and research teams should now take to restart research. These are available to read and download in the drop down menu - Documents - below.
Our plans are being developed in line with the National Institute for Health Research restart framework https://www.nihr.ac.uk/documents/restart-framework/24886 and guidance from the Government including how to travel safely and working in indoor labs and research facilities and similar environments.
For more information
If you are a Principal Investigator or a researcher involved in clinical research at Nottingham University Hospitals, the NIHR Nottingham Biomedical Research Centre or the NIHR Nottingham Clinical Research Facility please email us if you have any questions about the Research Restart process.
Explaining the restart process
The process for Research Restart is explained in the document below. Please read this before completing the Study Restart document.
Please complete and return
Please complete the Study Restart document below, to request the resumption or the initiation of your research.
- PDF version Study Restart Document A4-v2.pdf [pdf] 73KB or
- Word version Study Restart Document WordV2.0.docx[docx] 82KB
To help you complete your request
This guidance document aims to provide additional information to help you complete the Study Research document.
Frequently Asked Questions
The latest version of FAQs on Research Restart are available below:
Patient screening questionnaire
Questionnaire to be completed for all patients attending NUH for research appointments. Please download a copy.
This is the latest version of the staff resource plan. Clinical Research Workforce Delivery Plan A4-v2.pdf [pdf] 2MB
Working from the R&I offices from 1 September onwards
Clinical Research Patient Pathway
Flow diagram for managing patient appointments as part of Restart.
Using video consultations in the NHS
Guidance for NHS staff on the best use of video consultations.
Information for patients and carers
Please find below information about restarting our research and different ways of involving patients and the public in our research. Please click on the link to view or download.